Multiple paxillin binding sites regulate FAK function

Furuta Y, Ilic D, Kanazawa S, Takeda N, Yamamoto T, Aizawa S: Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene 1995, 11:1989–1995. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO: Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079–1091. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM: The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 2002, 22:901–915. Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001, 1540:1–21. Hanks SK, Ryzhova L, Shin NY, Brabek J: Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003, 8:d982-d996. Calalb MB, Polte TR, Hanks SK: Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995, 15:954–963. Calalb MB, Zhang X, Polte TR, Hanks SK: Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem Biophys Res Commun 1996, 228:662–668. Schlaepfer DD, Hanks SK, Hunter T, van der GP: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994, 372:786–791. Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA: Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 2002, 157:149–160. Katz BZ, Romer L, Miyamoto S, Volberg T, Matsumoto K, Cukierman E, Geiger B, Yamada KM: Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases. J Biol Chem 2003, 278:29115–29120. Ezratty EJ, Partridge MA, Gundersen GG: Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol 2005, 7:581–590. Shen Y, Schaller MD: Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation. Mol Biol Cell 1999, 10:2507–2518. Hildebrand JD, Schaller MD, Parsons JT: Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 1993, 123:993–1005. Hildebrand JD, Schaller MD, Parsons JT: Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell 1995, 6:637–647. Chen HC, Appeddu PA, Parsons JT, Hildebrand JD, Schaller MD, Guan JL: Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995, 270:16995–16999. Brown MC, Turner CE: Paxillin: adapting to change. Physiol Rev 2004, 84:1315–1339. Turner CE, Miller JT: Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. J Cell Sci 1994, 107 ( Pt 6):1583–1591. Thomas JW, Cooley MA, Broome JM, Salgia R, Griffin JD, Lombardo CR, Schaller MD: The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin. J Biol Chem 1999, 274:36684–36692. Wade R, Bohl J, Vande PS: Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 2002, 21:96–107. Liu G, Guibao CD, Zheng J: Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase. Mol Cell Biol 2002, 22:2751–2760. Arold ST, Hoellerer MK, Noble MEM: The structural basis of localization and signaling by the focal adhesion targeting domain. Structure 2002, 10:319–327. Hayashi I, Vuori K, Liddington RC: The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin. Nat Struct Biol 2002, 9:101–106. Prutzman KC, Gao G, King ML, Iyer VV, Mueller GA, Schaller MD, Campbell SL: The focal adhesion targeting domain of focal adhesion kinase contains a hinge region that modulates tyrosine 926 phosphorylation. Structure 2004, 12:881–891. Gao G, Prutzman KC, King ML, Scheswohl DM, DeRose EF, London RE, Schaller MD, Campbell SL: NMR Solution Structure of the Focal Adhesion Targeting Domain of Focal Adhesion Kinase in Complex with a Paxillin LD Peptide: EVIDENCE FOR A TWO-SITE BINDING MODEL. J Biol Chem 2004, 279:8441–8451. Bertolucci CM, Guibao CD, Zheng J: Structural features of the focal adhesion kinase-paxillin complex give insight into the dynamics of focal adhesion assembly. Protein Sci 2005, 14:644–652. Gabarra-Niecko V, Keely PJ, Schaller MD: Characterization of an Activated Mutant of Focal Adhesion Kinase: SuperFAK. Biochem J 2002, 365:591–603. Zheng C, Xing Z, Bian ZC, Guo C, Akbay A, Warner L, Guan JL: Differential regulation of Pyk2 and focal adhesion kinase (FAK). The C- terminal domain of FAK confers response to cell adhesion. J Biol Chem 1998, 273:2384–2389. Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I: Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochemical Journal 2001, 360:255–264. Nakamura K, Yano H, Schaefer E, Sabe HA: Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene 2001, 20:2626–2635. Vadlamudi RK, Sahin AA, Adam L, Wang RA, Kumar R: Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215. Febs Letters 2003, 543:76–80. Gabarra-Niecko V, Schaller MD, Dunty JM: FAK regulates biological processes important for the pathogenesis of cancer. Cancer and Metastasis Reviews 2003, 22:359–374. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005, 5:505–515. Xu LH, Yang X, Craven RJ, Cance WG: The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ 1998, 9:999–1005. Hauck CR, Hsia DA, Puente XS, Cheresh DA, Schlaepfer DD: FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J 2002, 21:6289–6302. van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de WB: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 2005, 65:4698–4706. Schaller MD, Borgman CA, Parsons JT: Autonomous expression of a noncatalytic domain of the focal adhesion- associated protein tyrosine kinase pp125FAK. Mol Cell Biol 1993, 13:785–791. Cooley MA, Broome JM, Ohngemach C, Romer LH, Schaller MD: Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase. Mol Biol Cell 2000, 11:3247–3263. Reynolds AB, Roesel DJ, Kanner SB, Parsons JT: Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol 1989, 9:629–638. Schaller MD, Parsons JT: pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high- affinity binding site for Crk. Mol Cell Biol 1995, 15:2635–2645. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A 1992, 89:5192–5196.